著者

下石 和樹 安楽 誠 庵原 大輔 平山 文俊 門脇 大介 陣上 祥子 丸山 徹 小田切 優樹

出版者

一般社団法人日本医療薬学会

雑誌

医療薬学 (ISSN:1346342X)

巻号頁・発行日

vol.44, no.2, pp.55-60, 2018-02-10 (Released:2019-02-10)

参考文献数

8

---

Because it is essential to restrict phosphorus intake in dialysis patients, we investigated the phosphorus content per daily standard dose for eight different types of Chinese medicine and 12 different supplements, all of which are typically used by dialysis patients. Phosphorous contents in the range of 3-12 mg were detected in all of the Chinese medicines. Although 11 of the 12 kinds of supplements contained phosphorous, the levels were less than those in the Chinese medicines. The highest phosphorus content among those supplements was found in glucosamine, with a phosphorous content of 6 mg per dose. The phosphorous contents of glucosamine samples obtained from five different companies were all different. Taking these findings together, the intake of phosphorus by dialysis patients heeds to be restricted and the phosphorus contents of Chinese medicines and supplements need to be taken into consideration, by evaluating the total phosphorus intake per day for such patients. Pharmacists should pay attention to maintaining the serum phosphorus level within a reference value by effectively using a phosphate binder if necessary.